Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal

Functional rafts in cell membranes

Kai Simons, Elina Ikonen · Nature · 1997 · 9.7K citations

Life Sciences, Biochemistry, Cell Biology +14

Reduced Food Intake and Body Weight in Mice Treated with Fatty Acid Synthase Inhibitors

Thomas M. Loftus, Donna E. Jaworsky, Gojeb L. Frehywot et al. · Science · 2000 · 1K citations

Life Sciences, Neuroscience, Pharmacology +17

Fatty acid synthesis: a potential selective target for antineoplastic therapy.

Francis P. Kuhajda, K Jenner, F D Wood et al. · Proceedings of the National Academy of Sciences · 1994 · 703 citations

Life Sciences, Oncology, Cancer Pharmacology +15

Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity

Steven J. Kridel, Fumiko Axelrod, Natasha Rozenkrantz et al. · Cancer Research · 2004 · 601 citations · Full text

Medicine, Oncology, Pharmacology +16

Synthesis and antitumor activity of an inhibitor of fatty acid synthase

Francis P. Kuhajda, Ellen S. Pizer, Ji Nong Li et al. · Proceedings of the National Academy of Sciences · 2000 · 565 citations

Life Sciences, Oncology, Pharmacology +16